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Introduction 
 
 The Centers for Disease Control (CDC, 2014) identifies depression as a serious medical 
illness that can negatively impact a person across all domains of life.  Elderly adults, aged 65 and 
older, are at increased risk for depression because approximately 80% have at least one chronic 
health condition–depression is a common co-morbid mental disorder among people with 
ongoing, persistent illnesses (CDC, 2014). Older adults homebound with chronic health 
conditions use home healthcare (HH) services to help them and their caregivers manage their 
illnesses at home and prevent hospitalizations. Although depression in this population is 
associated with increased rates of re-hospitalization, falls, and suicides, it is frequently under 
diagnosed and under treated (Sheeran, Byers, & Bruce, 2010; Byers et al., 2008; Raue et al., 
2006; CDC, 2014).  While clinicians who provide care in the home are well positioned to 
identify depressive symptoms in their patients they must have agency and federal-level 
stakeholder support to reasonably meet the depression care needs of their patients.  
 This capstone report presents three manuscripts that explore the provision of depression 
care in the HH population.  The first report is a literature review of 30 articles investigating 
depression screening and depression care in HH patients.  Three main themes emerged from the 
research: the scope of the problem, depression screening tools, and depression care.  Though 
many barriers hinder the recognition and treatment of depression in this population, training HH 
professionals and working with specialized mental health providers can improve depression 
screening and care.  
 The results of the literature review guided the development and implementation of a 
depressive disorder protocol in a HH agency designed to improve recognition of depression in 
HH patients and then facilitate connection to care.  The second manuscript describes a process 
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evaluation of HH clinician fidelity of the protocol and other important process outcomes 
associated with implementation.  This report concludes by identifying ways in which the Doctor 
of Nursing Practice prepared nurse can promote positive practice change in this area.  
 The final document is a policy position statement that examines the problem of under 
identified and under treated depression in HH and then identifies evidence-based interventions 
designed to improve depression care in this population.  This report culminates with 
recommendations for policy change that will encourage and support HH agencies and clinicians 
who chose to provide holistic chronic care management by adopting innovative depression care 
models.  
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Depression Screening and Care in Home Health: A Review of the Literature 
  Each day approximately 1.5 million Americans receive home healthcare (HH) from 
greater than 33,000 providers (National Association for Home Care and Hospice, 2010).  HH 
agencies provide health and social services to chronically ill, homebound older adults who need 
intermittent skilled nursing care and/or physical, occupational, or speech-language therapies with 
the goal of improving the patient and caregiver’s ability to manage illness at home (U.S. 
Department of Health and Human Services, Centers for Medicare and Medicaid Services, 2014).    
Most HH patients are over the age of 65 and the majority of them carry a chronic health 
diagnosis (Caffrey, Sengupta, Moss, Harris-Kojetin, & Valverde, 2011).  In a report released by 
the Centers for Disease Control (CDC) in 2011, diabetes (10.1%), heart disease (8.8%), 
congestive heart failure (4.3%), malignant neoplasm (3.9%), chronic obstructive pulmonary 
disease (3.4%), hypertension (3.4%), and stroke (3.3%) were the most common HH admission 
diagnoses.  Furthermore, these patients commonly suffered from significant functional 
impairment (84%), falls, and lack of caregiver involvement (Caffrey et al., 2011). 
 These ongoing physical and functional stressors place HH patients at risk for depression, 
a mental health disorder characterized by anhedonia (inability to experience pleasure), lack of 
energy, and feelings of sadness, hopelessness, and helplessness (Pickett, Raue, & Bruce, 2012; 
Shao, Peng, Bruce, & Bao, 2011; American Psychiatric Association, 2013).  Significant rates of 
comorbid depression have been identified in patients with conditions such as diabetes, heart 
failure, and fall risk (Acee, 2014; Mantysekla et al., 2011; Thomas et al., 2008; Byers et al., 
2008).  Furthermore, depression increases HH patients’ risk for re-hospitalization, poorer quality 
of life, and suicidal ideation (Sheeran, Byers, & Bruce, 2010; Raue, Meyers, Rowe, Heo, & 
Bruce, 2006; Diefenbach, Tolin, & Gilliam, 2011).  
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 In 2010, Qui et al. summarized the risk factors attributable to older adults becoming and 
remaining homebound, reporting that patients in need of HH “suffer from physical and 
psychiatric illnesses at a much higher rate than non-homebound adults” (p. 2423). Additionally, 
depression is reported to be the second most prevalent psychiatric illness among HH patients 
(Qui et al., 2010).  The following review will examine trends in screening for depression in HH, 
then analyze evidence regarding the use of standardized screening tools, clinician training, and 
agency protocols to facilitate the identification and treatment of depression in HH patients. 
Methods 
Literature Review 
 A review of the literature was conducted using the following electronic databases from 
the University of Kentucky Medical Center Library: CINAHL, MEDLINE, PubMed, TRIP, and 
PsycINFO.  Google and Google Scholar were also used to search for evidence regarding 
depression screening in the HH population.  The following search terms were used to find 
relevant literature:  home care, home healthcare, aging/older adults, elderly, screen, detect, 
identify, recognize, consequences, chronic illness, diabetes, congestive heart failure, cancer, 
comorbidity, mental illness, mood disorder, depression, major depressive disorder, exacerbation, 
importance, health outcomes, improve, enhance, develop, elevate, advance, risk (factors), 
contributing (factors), rates, statistics, Medicare, and Centers for Medicare and Medicaid (CMS).  
Ancestry searching was also used to find relevant literature.  Unpublished studies were not 
examined.  Articles were reviewed considering inclusion and exclusion criteria.  
Inclusion/Exclusion Criteria 
 The analyzed evidence included systematic and integrative literature reviews, randomized 
and nonrandomized experimental studies, and non-experimental studies.  Articles that focused on 
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prevalence, barriers to screening, improving screening, depression care management, and 
depression treatment outcomes in HH were included.  Articles published before 2000 and 
research studies conducted in other countries were excluded from this review to ensure relevance 
to the current HH system in the United States.  Research involving the pediatric population was 
also excluded, as the elderly are the focus of this review.  Literature describing screening for 
depression involving patients with severe dementia was not included because standard 
depression screening tools were not normed for cognitively impaired patients and, therefore, 
were not reliable tools for use with this population (Sheeran, Reilly, Weinberger, Bruce, & 
Pomerantz, 2010).  Only in the past fifteen years has depression in HH been of focus in the 
literature.  As a result, articles from as early as 2002 were included.   
 The initial search yielded 35 articles, which were narrowed to 30 after removal of five not 
specific to the HH population.  Of the 30 articles, four were randomized controlled trials, five 
were nonrandomized controlled trials, seven were observational clinical studies, three were 
policy briefs, five were clinical intervention descriptions, five were literature reviews, and one 
was a qualitative study.   
Results 
 The search produced articles with varying perspectives on depression screening in HH.  
The following themes were discovered in analysis of the resulting literature: scope of the 
problem, depression screening tools, and depression care models.  These themes will be 
reviewed as they relate to trends in depression screening.  Finally, a discussion will incorporate 
literature found regarding the importance of engaging stakeholders in depression screening and 
treatment programs in HH.  
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Scope of the Problem 
 Rates of depression.  Using the Structured Clinical Interview for DSM-IV-Depression, 
Bruce et al. (2002) interviewed 539 HH patients and determined that 13.5 % met DSM-IV 
criteria for major depression and 10.8 for minor depression.  Nine years later, Shao, Peng, Bruce, 
and Bao (2011) analyzed data from the 2007 National Home and Hospice Care Survey and found 
that according to physicians and home health care agencies, 6.4% of the home care population 
met criteria for depression.  Gellis (2010) reported a 5.7% prevalence rate of major depression 
symptoms in his sample and a 16.4% prevalence rate of sub threshold depressive disorder.  This 
discrepancy (Shao et al., 2011) has raised concerns that depression is under-recognized and 
under-treated in patients receiving HH (Brown, Kaiser, & Gellis, 2007).   
 Untreated depression.  Rates of clinically significant depression in HH patients have 
been described to be as low as 8.5% and as high as 25% (Ell et al., 2007; Bruce et al., 2002).  
Bruce et al. (2002) stated that just as there are concerns that depression often goes undetected in 
this population, there is evidence to suggest that it is also substantially undertreated.  Of 73 HH 
patients who met the criteria for major depression, only 16 (22%) were being treated with 
antidepressants and none were involved with counseling or psychotherapy (Bruce et al., 2002).  
Furthermore, five (31%) of the 16 patients taking antidepressants were not taking therapeutic 
doses and two reported not taking the medication as directed (Bruce et al., 2002).  Adequate 
depression screening can be an important first step in connecting depressed HH patients to 
effective care measures.  
 HH patients who are depressed, not effectively treated, and continue to meet criteria for 
depressive disorders have increased short-term risk of hospitalization (Sheeran, Byers, & Bruce, 
2010) and high rates of suicidal ideation (11.7%; Raue et al., 2006) soon after starting home care 
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services.  Anecdotally, symptoms of depression can also hinder and decrease patient engagement 
in treatment with physical and occupational therapies intended to improve functional status 
(Acee, 2014).  These examples highlight the importance of establishing adequate depression-
screening protocols that will quickly link HH patients to depression care interventions soon after 
admission to HH. 
 Barriers to effective depression screening and care.  Many barriers prohibit effective 
depression screening in HH.  Patient factors such as stigmatization and poor acceptance of 
mental illness, especially in older adults, can result in underreporting of depressive symptoms 
(Brown, Kaiser, & Gellis, 2007; Valente, 2005).  Racial disparities in the identification and 
effective treatment of depression have also been noted–older African-Americans are less likely 
to be screened for depression compared to Caucasians (Pickett, Raue, & Bruce, 2012).  
 Clinician factors can also contribute to poor depression screening and care.  Studies 
indicate that nurses and other HH clinicians report receiving inadequate training on how to 
screen for depression (Brown, Kaiser, & Gellis, 2007; Brown et al., 2010; Bruce et al., 2007; 
Liebel & Powers, 2013; Valente, 2005).  In a qualitative study of nurses’ perceptions of 
depression care management researchers found that subjects were more comfortable managing 
physical illness and less confident in their ability to provide accurate depression psychoeducation 
and care (Liebel & Powers, 2013).  Also, treating comorbid chronic illness can be time-
consuming.  HH clinicians may already feel overextended and perceive depression screening as 
just another task they must complete, resulting in ineffective use of the tools (Valente, 2005).  
The misperception that depression is a normal part of aging and the masking of depressive 
symptoms by physical/medical illnesses can also prevent effective depression screening and 
connection to care (Valente, 2005).  Interestingly, clinicians appear to have less confidence in 
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their ability to identify and manage depression compared to other chronic illnesses commonly 
found in HH patients (Brown et al., 2010, Liebel & Powers, 2013), especially if they are not 
aware of how to connect their patients with appropriate depression care resources (Liebel & 
Powers, 2013).  
 Medicare policies regulating HH practice and reimbursement also appear to present 
unfortunate limitations.  Bao, Eggman, Richardson, and Bruce (2014) reported on a qualitative 
study of interviews with nurses and administrators from five HH agencies in which their 
perspectives on the feasibility of providing effective and evidence-based depression care were 
analyzed.  Results indicated that the way HH agencies were paid did not align with providing 
quality depression screening and care.  The prospective payment system (PPS) pays HH agencies 
a fixed, lump sum based on patients’ diagnosis group.  Nurses are held to productivity 
requirements, usually requiring them to see six to eight patients daily.  In the study screening and 
treating depression required a great deal of time for some patients.  However, the payment 
system and productivity requirements remained the same whether the nurse just completes tasks 
or if he or she spends adequate time carefully assessing and providing quality care.  While some 
nurses reported wanting to spend more time with complex, depressed patients they reported 
feeling pressured by productivity requirements to quickly rather than thoroughly complete 
depression care tasks (Bao, Eggman, Richardson, & Bruce, 2014).    
 Clinicians are required to complete the Outcomes Assessment and Information Set 
(OASIS-C), which is a series of questions used to report functional and clinical data on each 
patient and determine appropriate service utilization.  This information is also used to determine 
how much the HH agency will be paid for the patient’s care each 60-day episode.  Responses on 
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this form are completed in full at start of care (SOC) and resumption of care (ROC), while 
reduced versions are completed at recertification and discharge.   
 Until the past decade, there has been a lack of importance placed on depression screening 
and intervention in HH at the policy and regulatory levels.  Historically, CMS and the Medicare 
Home Health Benefit have neither regulated, mandated, nor offered any financial incentives for 
implementing evidence-based depression screening and care with HH patients (Cabin, 2010).  
Although there have been important changes made to the required OASIS assessments and 
required documentation, clinicians still report feeling unsupported by Medicare policy (Bao et 
al., 2014).  As Bao et al. (2014) report, “Medicare’s homebound and skilled need eligibility 
requirements, inclusion of depression assessment only in the start of care (SOC) OASIS but not 
at other time points, and lack of minimum standards for vendor developed home health 
electronic health records (EHR) to support depression care are at odds with evidence-based 
depression care and the chronic nature of depression” (p. 908).  
Depression Screening Tools  
 Depression screening in home healthcare.  Over the past four years there have been 
significant changes to the way HH clinicians are prompted to screen for depression on the 
OASIS.  Before 2010, clinicians admitting patients to HH used question M0590 on the OASIS, 
which was not a standardized tool and only measured one of the two “gateway” symptoms of 
depression (Sheeran et al., 2010).  Updated in 2010, the OASIS-C now includes item M1730, 
which asks clinicians if they have screened their patient for depression using the Patient Health 
Questionnaire-2 (PHQ-2) or another tool.  This approach prompts the admitting clinician to 
screen for depression, provides the PHQ-2 for a quick two-question screen, and allows for other 
tools to be used if appropriate.  Including an easy to use measure increases the likelihood that 
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overwhelmed HH clinicians will take the time to screen their patients for depression (Cabin, 
2010; Sheeran et al., 2010).  Additionally, the PHQ-2 is now being used more frequently in 
primary care clinics.  This enables HH clinicians to communicate about patients’ depressive 
symptoms with primary care providers, increasing their ability to work together in the 
assessment and treatment of their elderly, homebound patients (Sheeran et al., 2010).   
 Including the PHQ-2 on the OASIS-C improves depression screening of HH patients by 
providing clinicians with a valid tool (Chunyu et al., 2007) that assesses both of the main 
symptoms of major depression: depressed mood and anhedonia (Sheeran et al., 2010).  Chunyu 
et al. (2007) evaluated the PHQ-2’s criterion validity against the diagnostic criteria for 
depression and construct validity with the six scales of the Medical Outcomes Study 12-item 
Short Form Questionnaire.  At a score of two or greater, with a sensitivity of 100% and a 
specificity of 77% for major depressive disorder in older adults (Chunyu et al., 2007), this 
screening tool can help HH clinicians determine who may need further screening and 
intervention (Sheeran, et al., 2010).  
 While the PHQ-2 has been determined to be a valid and reliable screening tool in older 
adults, with a sensitivity of 77%, Chunyu (2007) recommended that a more in-depth tool be 
administered if the patient screens positive for depression.  The Patient Health Questionnaire-9 
(PHQ-9) is one such tool used to follow up positive screens on the PHQ-2.  It has been found 
that routine depression screening of HH patients using the PHQ-9 is relatively easy to implement 
and can help to identify depression in this population (Ell et al., 2005; Ell et al., 2009).  Bruce et 
al. (2011) recommend using the PHQ-9 because it is an “efficient, evidence based approach to 
quantifying depression severity and changes in severity over time” (p. 483).  Like the PHQ-2, the 
PHQ-9 is commonly used in primary care, and can therefore be more easily discussed and 
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understood between clinicians than the previously used OASIS question (Bruce et al., 2011).  As 
aforementioned, the HH clinician can opt to use a different depression screener.  Madden-Barer 
et al. (2013) reported that the Geriatric Depression Scale (GDS), when used as part of a larger 
depression care management program, effectively screens for and measures symptom severity 
over time.  Like the PHQ-9, the GDS is longer than the PHQ-2, with fifteen items (McCormack 
et al., 2011).  The sensitivity and specificity are comparable to that of the PHQ-9 (Madden-Barer 
et al., 2013).  
 Furthermore, Gellis (2010) describes a depression-screening model HOME: Home Care 
and Mental Health for the Elderly.  In this model, the eleven-item Center for Epidemiological 
Studies-Depression screening tool (CES-D) was completed at SOC.  However, in this study it 
was found that depression severity was inaccurately assessed using the CES-D.  Importantly, this 
was thought not attributable to the properties of the standardized screening tool, but to be more a 
function of patient underreporting of symptoms, lack of rapport with the clinician, and clinician 
attempts to reduce the number of false positive referrals to the depression care program (Gellis, 
2010).   
 In sum, while the PHQ-2 is a simple, 2-question tool that improves the likelihood that 
HH clinicians will actually screen their patients for depression, its questionable reliability and 
sensitivity warrant a more thorough investigation of depressive symptoms.  The PHQ-9, GDS, 
and CES-D can be confidently used to follow-up positive screens of the PHQ-2.  Furthermore, 
none of the previously mentioned tools should be used in isolation to make a diagnosis of 
depression by a qualified health professional. 
 Training to improve depression screening.  Evidence suggests that training clinicians 
to screen for depression can improve their ability to effectively complete the task (Brown et al., 
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2010; Bruce et al., 2007).  Both Gellis (2010) and Bruce et al. (2007) trained agency clinicians 
on depression screening and the protocols for depression care referrals.  Educators used 
strategies such as didactic instruction on depression screening, tool kits on the measurement 
tools, video, role-playing, and behavior rehearsal with case examples.  
 In addition, agencies benefit from working with specialized mental health professionals 
when developing and implementing these training protocols (Gellis, 2010; Madden-Baer et al., 
2013).  A key component of Gellis’ (2010) training for the HOME program was the use of a 
specialized, interdisciplinary team consisting of social workers, a mental health therapist, PhD-
level geriatric depression specialist, and a nurse supervisor.  This team worked together to 
develop and disseminate the depression-screening training throughout the agency.  The study 
compared trained clinician scores of depression on the CES-D to researchers’ scores on the 
Structured Clinical Interview for Diagnostic and Statistical Manual-IV (SCID-IV).  There was a 
fair to moderate agreement between researcher and trained-nurse ratings of depression (Gellis, 
2010).  
 Similarly, the Training In the Assessment of Depression (TRIAD) intervention was 
developed through collaboration between the involved agencies and researchers to avoid 
“increasing nurse burden, devaluing nurses’ clinical skills, or further stigmatizing depression” 
(Bruce et al., 2007, p. 1794).  Bruce et al.’s (2007) RCT compared trained nurses’ assessment of 
depression using OASIS item M0590 (OASIS item used to screen for depression before changes 
in 2010) to researchers’ assessment of depression symptoms using the SCID-IV.  There was no 
significant difference in depression ratings between groups and, furthermore, trained nurses 
assessments led to appropriate referrals for depression care treatment (Bruce et al., 2007).  
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 Madden-Baer et al. (2013) used a team of “specialty-trained psychiatric home care 
nurses” (p. 34) to screen for depression in their large HH agency.  Psychiatric mental-health 
nurses have specific education and/or clinical experience in the field of mental health beyond 
what is required of a traditional registered nurse.  CMS dictates the requirements needed for a 
mental health nurse (MHN) to become Medicare-certified.  These requirements vary depending 
on the education level and years of clinical experience in psychiatric and mental health nursing, 
but must be met in order for the care provided by the mental health nurse to be reimbursable 
through Medicare (Thobaben, 2013).   
 The authors (Madden-Baer et al., 2013) conducted a retrospective chart review from 
September 2010 to September 2011 to determine if an evidence-based depression care 
management (DCM) protocol can be implemented in a financially, operationally, and clinically 
feasible manner at the Visiting Nurse Service of New York. The MHNs used the GDS to screen 
for depression and used cognitive-behavioral therapy (CBT) techniques to assist patients with 
goal setting and exploring negative thoughts and feelings. The MHNs also provided medication 
monitoring and psychoeducation. Additionally, psychiatrists and psychiatric nurse practitioners 
provided home-based evaluations and consultations including recommendations for medications 
that were communicated to primary care providers.  In this case, using specialty mental health 
nurses led to accurate screening and improved access to depression care, reducing patients’ 
symptoms of depression.  This highlights the need for including specialized training, education, 
and/or experience with depression screening–it is not sufficient to simply include a depression 
screener in an admission protocol.  Clinicians must be familiar with the tool and the mental 
health disorder as it presents in elderly, homebound patients.  
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 Therefore, Sheeran et al. (2010) provided an in-depth review of the history of depression 
screening included on the OASIS and described the rationale for including the PHQ-2 on the 
tool.  This descriptive review reads as a training guideline educators can use to orient HH 
clinicians to depression screening.  Sheeran et al. (2010) highlight the need to describe major 
depression and screening and treatment barriers in the HH population.  Also, the PHQ-2 should 
be thoroughly understood by HH clinicians as should methods for discussing depression 
treatment with patients and making appropriate referrals for care (Sheeran et al., 2010).   
Screening as Part of Larger Depression Care Models 
 The U.S. Preventative Services Task Force (USPSTF, 2012) provides screening 
recommendations for adults; however, these are not specific to geriatrics or HH.  The 
recommendations state that routine screening for depression is suggested only if there are proper 
supports in place to ensure accurate diagnosis, treatment, and follow-up.  Evidence suggests that 
providing depression care management in the home can alleviate depressive symptoms in 
homebound adults (Cabin, 2010; Ell et al., 2007; Madden-Baer et al., 2013).  For that reason, the 
Community Preventative Services Task Force (2014) recommends depression care at home when 
indicated. 
 Over the past decade innovative depression care programs have been developed to meet 
this need.  Accurate depression screening must precede depression treatment and, therefore, is 
included in all of these programs.  Results of the depression screening should guide clinicians as 
they determine if patients are appropriate for depression care programming (Bruce et al., 2011a; 
Bruce et al., 2011b; Ell et al., 2005; Ell et al., 2007; Gellis, 2010; Gellis, Kenaley, & Have, 2014; 
Madden-Baer et al., 2013).  These programs vary in terms of the screening tools and treatment 
modalities used as well as in the mental health professionals available for consultation and 
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collaboration.  Depression care models such as I-TEAM (Gellis, Kenaley, & Have, 2014), 
HOME (Gellis, 2010), Visiting Nurse Service of New York’s Behavior Health Program 
(Madden-Baer et al., 2013), and Homecare to Overcome Problems of Elders with Depression 
(HOPE-D; Ell et al., 2005; Ell et al., 2007) were developed with the available resources and 
infrastructure already in place within their respective HH agencies and surrounding communities.  
 The HOPE-D (Ell et al., 2007) intervention was designed to improve quality of 
depression care to HH patients by including routine depression screening using the PHQ-9 and 
collaborative care elements such as using a depression care manager and psychiatric prescriber, 
outcome measurement, and algorithm-based care similar to that used in the IMPACT outpatient 
intervention (Untzer, Harbin, & Schoenbaum, 2013).  Patients who did not receive the 
intervention did receive enhanced care as usual, which was provided by nurses newly trained on 
depression screening and care techniques (Ell et al., 2007).  While depression scores of patients 
who received care in the intervention group were consistently better, the differences did not 
reach statistical significance. Researchers believe training the entire nursing staff on depression 
management and implementing new techniques in both groups enhanced nursing care regardless 
of whether or not the algorithm was used.  Of most significance, this study demonstrated that 
training staff and implementing depression care is feasible and can improve depressive 
symptoms (Ell et al., 2007).  
  Bruce et al. (2011a) and Bruce et al. (2011b) developed CAREPATH as a result of their 
2007 trial (Bruce et al., 2007) evaluating the impact of depression screening training on 
depression evaluation and referral skills.  Built around the use of the PHQ-2 imbedded in the 
OASIS-C, they provide a detailed guide for developing depression care programs in Medicare-
certified HH agencies.  The authors emphasize that program developers must be cognizant of 
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policies and procedures that are unique to each agency and encourage developers to consider 
ways in which the HH infrastructure must support the program (Bruce et al., 2011a).  For 
instance, CAREPATH’s guidelines for case coordination are adaptive depending upon the 
resources available to the HH.  As the authors pointed out, “Typically these guidelines require 
clinicians to contact the patient’s physician, although agencies with psychiatric nurses, clinically 
trained social workers, or access to other mental health specialists may designate these clinicians 
as the initial point of contact.” (Bruce et al., 2011b, p. 484).  
 Researches launched a large-scale, randomized trial involving six agencies to determine 
if patients who receive the CAREPATH intervention show greater improvements in depression 
scores compared to patients who receive usual care as determined by each individual agency 
(Bruce et al., 2015). Patients who scored 3 or greater on the PHQ-2 were eligible for 
randomization to either group. The CAREPATH intervention provided clinicians with a clinical 
protocol and agency support for depression care. CAREPATH encourages agencies to train all 
nurses to deliver depression care management if indicated with patient scores 3 or greater on the 
PHQ-2.  The protocol directs nurses to further assess depression using the PHQ-9 to focus 
resources on patients who have the greatest need for depression care. Investigators used the 
Hamilton Scale for Depression (HAM-D) to measure the intervention.  The results showed that, 
while in the full sample the intervention had no effect, patients with severe depression who 
participated in CAREPATH had lower depression scores compared to similar patients who 
received usual depression care.  
 Using their agency’s available resources, Gellis, Kenaley, and Have (2014) developed an 
innovative telehealth model known as I-TEAM for depression care provided to HH patients–the 
only use of telehealth in the literature reviewed.  The PHQ-2 was used to screen for depression in 
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a moderately large (9,000 patients annually) HH agency.  Patients who scored three or greater 
were included in this study and were randomly assigned to either care as usual or the treatment 
group. The intervention consisted of remote assessment and treatment of chronic illnesses such 
as congestive heart failure, alongside treatment of depression using a focused, problem-solving 
approach.  Pre and post depression scores using the PHQ-9 and the Hamilton Depression Rating 
Scale were compared to a group of HH who scored 3 or greater on the PHQ-2 at admission, but 
received care as usual (psychoeducation, medication management, etc.).  PHQ-9 and Hamilton 
Depression Ration Scale scores were 50% lower in the treatment (I-TEAM) group compared to 
those who received care as usual.   
 Overall, the literature reviewed pointed to the importance of adopting screening and 
treatment protocols that could make use of and work with existing resources as much as possible 
(Bruce et al., 2011b).  While some additional policies and procedures may need to be 
implemented to promote safety and quality, successful depression care programming is careful to 
minimize financial and work burden to the agency and keep all stakeholders’ goals in mind  
Discussion 
 Over the past six years there have been some policy changes within the Centers for 
Medicare and Medicaid (CMS) that have improved HH clinician access to standardized 
screening tools for depression.  However, several barriers to depression screening and care still 
exist in this setting.  For instance, screening for depression is not mandatory (Cabin, 2010).  
Furthermore, while the PHQ-2 is included on the OASIS-C and it is recommended that a positive 
screen be followed-up with a more in-depth evaluation, CMS provides no guidance concerning 
the most appropriate instruments to use.  This may result in difficulty comparing depression 
scores and program effectiveness across HH agencies. 
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 The most striking barriers, however, are at the organizational and financial levels.  While 
HH clinicians are prompted to screen for depression, there is no indication that scores will have 
any impact on Medicare payments (Bao et al., 2014; Cabin, 2010).  HH companies, therefore, 
have been reluctant to spend time and money on programming that will have little to no apparent 
financial benefit.   
 According to this review of the literature, DCM protocols that include depression 
screening have been developed but are sparsely implemented in HH agencies throughout the 
country.  Presumably this is because of the lack of support from CMS and the home health 
benefit in leveraging agency resources to address depression in this population.  Future research, 
then, should focus on describing the cost-effectiveness of implementing depression care 
management protocols in agencies across the country in a variety of settings and communities.  
Researchers should focus on combining recommendations for evidence-based depression 
screening and practice in the home with ways to make this programming financially feasible.  
This way, HH agencies will be more likely to embrace existing protocols.  Researchers may want 
to focus on highlighting how addressing depressive symptoms early on in the HH admission may 
cut down on costly re-hospitalizations, falls, and hip fractures, for example.  Overall, this body of 
research would be enhanced with the addition of more rigorous examples of depression care 
protocols implemented in clinically and cost-effective ways. 
Conclusions 
 Due to the HH population’s high risk for depression, screening and care management 
interventions for depression are recommended.  Changes to the OASIS-C assessment have 
improved clinician access to standardized screening; however, there is little financial benefit, nor 
other types of incentives, for HH agencies to promote DCM.  Furthermore, there are also patient 
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and clinician barriers that make screening for depression among HH patients difficult.  Future 
research should focus on examining not only the clinical benefit, but also the financial benefit of 
implementing such protocols.  Depression care management protocols that include cost-saving 
ideas may help put this body of research into much needed action all over the country.  
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Introduction 
 Homebound status, decreased functionality, and co-morbid chronic illnesses 
increase home healthcare (HH) patients’ risk for depression; the diagnosis of a chronic 
disease raises the likelihood of a depressive disorder (Center for Disease Control and 
Prevention, CDC, 2012).  Egede (2007) reported that the age-and-sex-adjusted odds ratio 
of having comorbid depression with any chronic disease is 2.6, meaning that the likelihood 
of having depression increases by 160% when an individual has a chronic illness. 
Elderly adults receiving HH experience depression at a disproportionately higher rate, with 
almost one third of home care patients meeting criteria for major depression (Pickett, Raue, 
& Bruce, 2012).  Home healthcare patients over 65 years of age more commonly have a 
diagnosis of depression compared with their same-age peers in primary care (Bruce et al., 
2002). 
Depression correlates with poorer health outcomes and greater healthcare costs (Katon, 
2011; Fulop, Strain, & Stettin, 2003). Depressive symptoms demonstrate a strong association 
with mortality in cancer and diabetes patients (Park, Katon, & Wolf, 2013) elevated rates of re-
hospitalization following acute myocardial infarctions (Reese, Freeland, Steinmeyer, Rich, 
Rackley, & Carney, 2011), and greater use of medical resources in patients with congestive 
heart failure (Fulop, Strain, & Stettin, 2003).  Despite the negative impact, depression often 
remains undetected and unaddressed in this population (Bruce et al., 2002; Brown, Kaiser, & 
Gellis, 2007). 
Screening for Depression in the Home Care Population 
Understanding the need to screen home health patients for depressive symptoms, in 
2010 the Centers for Medicare and Medicaid Services (CMS) included the Patient Health 
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Questionnaire-2 (PHQ-2; Appendix A) on the Outcome and Assessment Information Set-
Clinical (OASIS-C), an admission form required for all Medicare patients receiving HH. The 
PHQ-2, a standardized depression-screening tool, has proven reliable in detecting major 
depression in older adults (Chunyu, Friedman, Conwell, & Fiscella, 2007; Sheeran et al., 
2010). The PHQ-2 consists of two questions (the first two questions of the Patient Health 
Questionnaire-9; PHQ-9), which assess the main symptoms of major depression: depressed 
mood and anhedonia (i.e., the inability to experience pleasure).  Assessors ask patients to 
think about their mood over the previous two weeks and then answer the screening questions, 
indicating the frequency of the symptoms.  PHQ-2 scores can range from 0-6; a cutoff score 
of three or greater has a sensitivity of 87% and a specificity of 78% for major depressive 
disorder (Sheeran et al., 2010).  Therefore, researchers recommend that patients who score three 
or greater on the PHQ-2 should subsequently receive a more thorough evaluation (Bruce et 
al., 2011, Chunyu et al., 2007; Sheeran et al., 2010), such as the PHQ-9.  This screening 
tool—readily available from CMS—allows for easy administration with HH patients and can 
help identify depression in this population (Ell, Unutzer, Aranda, Sanchez, & Lee, 2005; Ell 
et al., 2007).   
Need for Training 
 While these tools are available in HH, many nurses say that they feel unprepared or 
inadequately trained to screen for depression (Brown, Kaiser, & Gellis, 2007; Brown, Raue, 
Boos, Sheeran, & Bruce, 2010; Bruce et al., 2007; Valente, 2005).  Nurses report feeling 
uncomfortable asking the screening questions because of fear of what the patient might say and 
then not knowing what to do with the answers (Liebel & Powers, 2013).  Providing nurses with 
depression care management training can resolve this problem (Bruce et al., 2015).  Nurses 
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trained to screen for depression and to use agency-specific protocols for connecting patients to 
depression care show increased confidence in their ability to complete the screening (Brown et 
al., 2010).  In addition, training improves nurses’ abilities both to identify patients who would 
benefit from further evaluation and care, and to complete the referral process (Bruce et al., 
2007).  For patients who have moderate-to-severe depression, a nurse-led combination screening 
and care management model can significantly decrease depression scores (Bruce et al., 2015).  
Although examples of depression care programming exist (Bruce et al., 2015), the resources 
required to complete depression screening and care may deter overextended HH clinicians and 
financially minded administrators (Bao, Eggman, Richardson, & Bruce, 2014; Valente, 2005).  
As a result, agencies must look for ways to reinforce depression screening and to build 
depression care into their existing operational structure and budget (Bao et al., 2014). 
Home Care Agency Background   
 In order to meet the depression care needs of its patients, a large HH agency in the 
Midwest developed and adopted a mental health program featuring a depressive disorder 
protocol.  The agency has an average monthly census of approximately 2,386 patients and served 
14,021 patients in 2014, approximately 61.5% of who receive Medicare (M. Brents, personal 
communication, March 2, 2015).  Operating six branches and employing approximately 150 
registered nurses and 90 therapists, this organization is the largest HH agency in the region (M. 
Brents, personal communication, March 2, 2015).  
 Prior to administration recognizing that the agency would benefit from formalized mental 
health programming, ten mental health nurses (MHN) managed the care of patients with mental 
illnesses across the service area.  Mental health nurses working in home care  “… have special 
training and/or experience beyond the standard curriculum required for a registered nurse (U.S 
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Department of Health and Human Services, 2011, p. 56).  These specially trained nurses provide 
evaluation, psychotherapy, and education required of patients presenting with mental health 
problems or recent changes in psychiatric care (U.S Department of Health and Human Services, 
2011).  Before the development and implementation of the depressive disorder protocol the 
agency had unclear standards for screening and the referral process for connecting patients to a 
MHN.  The newly designed depressive disorder protocol outlines specific steps for depression 
screening and guidelines for making a referral to a MHN within the agency for further evaluation 
and care (Appendix B). The purpose of this paper is to describe a process evaluation intended to 
measure clinician adherence to the depressive disorder protocol and other important process 
outcomes. 
Process Evaluation 
Objectives 
 The principal investigator (PI) conducted a process evaluation to assess HH clinician 
adherence (fidelity) to the depressive disorder protocol implemented at a HH agency during the 
summer of 2014.  Process evaluations yield important information concerning whether or not 
program protocols and interventions were implemented as intended (Grembowski, 2001). 
Measurement of fidelity, one important process evaluation component, tells us how well 
clinicians adhere to intervention procedures according to the program design (Hodges & Videto, 
2011). 
 The evaluation addressed the following questions: What is the level of HH clinician 
adherence to the program’s depressive disorder protocol?  Was there a difference in clinician 
screening and referral practices pre– versus post–program implementation? Agency leaders will 
use this information to determine how well the depressive disorder protocol is being followed and 
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to uncover significant barriers toward program implementation. Protocol adaptations will be 
made accordingly.   
The process evaluation also investigated whether patients who have clinically 
significant PHQ-2 scores were more likely to be diagnosed with depression. An additional 
goal was to determine if a PHQ-2 score of ≥ 3 is associated with changes in 
psychopharmacology treatment approaches after program implementation. The researcher 
sought to know if agency training could be associated with the frequency of which patients are 
prescribed an antidepressant or benzodiazepine while receiving HH.  A review of diagnoses 
will provide some indication of whether or not depression care programming is associated 
with changes in HH coding practices, which might indicate an increased awareness of 
depression in the agency and willingness to document it as a primary problem.  A review of 
pharmacologic interventions will allow program developers to determine if depression care 
programming is associated with appropriate psychopharmacological treatment choices for 
depressed HH patients.  
Methods 
Study design 
 A descriptive, retrospective design was used to examine the research questions. A 
convenience sample was selected for participation in the study. The Medical Institutional Review 
Board approved all study procedures prior to conducting the study. Procedures for ensuring 
participant anonymity and confidentiality were followed throughout the duration of the study.  
 Sample. The study sample consisted of all HH patients admitted to the agency between 
April 1, 2014 through April 30, 2014 and September 1, 2014 through September 30, 2014. All 
patient admissions during these time periods were reviewed to identify patients who met 
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inclusion criteria. Inclusion criteria were:  a HH patient aged 60 or older who had a Medicare 
health plan as their primary health insurance.  The researcher obtained additional data only from 
patients who scored ≥ 3 on the PHQ-2 screener at admission, because these scores trigger further 
action according to the protocol (Appendix B). Exclusion criteria were documentation of severe 
cognitive impairments and non-English speakers because these factors prevent accurate 
administration of the PHQ-2 screener.  
Study Procedures 
 Staff training. During the summer of 2014 all field clinicians who administer the OASIS-
C admission (registered nurses and therapists) completed two, one-hour training sessions consisting 
of didactic instruction and case study review on depression screening for HH patients. A total of 
250 staff members participated in the training.  The training included the following content: 
Appropriate administration of the PHQ-2 (Appendix C); identification of patients who need 
further evaluation by a MHN, according to the depressive disorder protocol (Appendix B); how 
to make an in-house referral for a MHN for further evaluation. In addition to the agency-wide 
training, the MHNs received two, three-hour training sessions reviewing the mental health 
program.  Approximately one hour of this training was spent reviewing and becoming familiar 
with the depressive disorder protocol and reviewing appropriate administration of the PHQ-2 and 
PHQ-9.  Mental health nurses were also made aware of how other field clinicians would be 
prompted to refer for a MHN evaluation.  
 Data extraction. The PI collected data from the EMR at the following time points: April 
1, 2014 through April 30, 2014 and September 1, 2014 through September 30, 2014. A total of 
1,318 OASIS-C admissions were reviewed. These included 664 patients that were admitted 
between April 1, 2014 and April 30, 2014, and 654 that were admitted between September 1, 
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2014 And September 30, 2014.  The researcher reviewed the EMR to obtain the following 
patient/admission information: age, race, sex, primary and secondary diagnoses, and 
medications. In addition, specific depression screening data were obtained, including presence of 
PHQ-2, PHQ-2 score, presence of MHN referral, reason for absence of a MHN referral in those 
with an indication, presence of PHQ-9, PHQ-9 score, and reason for absence of score in those 
with an indication. The PI extracted all data.  The researcher reviewed the data taken from each 
patient admission located on the EMR and then coded (Table 1) and recorded it on the 
demographic collection (Appendix E) and study variables extraction forms (Appendix F).    
 A master list containing patient identifiers and an assigned ID acted as the only link 
between the data and the patient record.  The researcher de-identified (except for the master list) 
and electronically saved the data on a password protected SPSS version 21 file on an encrypted, 
password protected thumb drive. All protected health information was accessed electronically 
and no printing or recording of protected health information occurred.  
 Data analysis. Means and standard deviations were used to measure characteristics of the 
study sample. Chi-square analysis with Yates' Continuity Correction was used to measure 
differences in the frequency of MHN referrals pre-and post training, and independent t-tests were 
used to measure differences in PHQ-2 scores pre-and post-intervention. In addition, Fisher's 
Exact Test was used to measure differences in the rates of PHQ-9 use pre-and post intervention. 
A p value of .05 was used for all analyses.  All statistical analyses were conducted using SPSS 
version 21. 
Results 
 Among the 1,318 admissions that had a documented PHQ-2 score, no significant 
differences appeared between the average PHQ-2 scores pre (M=0.40, SD=1.09) versus post 
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(M=0.42, SD=1.03) training. In addition, 30 pre-training patient admissions in April, and 28 
post-training admissions in September met criteria for further review (score of ≥ 3 on the PHQ-
9). Statistical analyses revealed no significant differences in demographics (age, sex, and 
ethnicity) between the patients of whom the admissions were reviewed pre vs. post groups 
(Table 2). A comparison of the PHQ-2 scores for the pre and post groups who met inclusion 
criteria (Table 3) indicated that there were no significant differences between the scores for pre-
intervention (M=4.67, SD=1.028) and post-intervention (M=4.21, SD=0.995; t (58) = 1.70, p = 
0.95, two-tailed).  
 No significant difference was found between the frequencies of clinicians making MHN 
referral when indicated pre vs. post intervention, χ2 (1, n=58) = .079, p = .778, (Table 3). The 
PHQ-9 was administered at a significantly higher rate in the post-intervention group (p = .038), 
but there was not a significantly higher average PHQ-9 score in the post-intervention group (pre: 
M = 7.5, SD = 4.9, post: M = 15.75, SD = 4.7), t (1.5) = 1.126, p = .208 (Table 3).  There were no 
significant differences found between pre– and post–intervention groups with respect to having a 
primary or secondary mood diagnosis (p = .905) or being prescribed an antidepressant (p = .80) 
or benzodiazepine (p = .72) during the HH episode(s) of care (Table 4).   
 Clinicians documented a total of six reasons for not adhering to the depressive disorder 
protocol (Table 5). Two patients refused a MHN evaluation pre-intervention and one patient 
post. Documented reasons for not following up positive screens of the PHQ-2 with the PHQ-9 
included, “GAD completed instead. Anxiety primary problem,” and “Geriatric depression scale 
used,” and “Not appropriate for patient presentation.”  Overall reasons for not adhering to the 
depressive disorder protocol were not well documented in either group, with a slight worsening 
of percentages post-intervention (Figure 1).  
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Discussion 
 After clinician training on the use of a newly implemented depressive disorder protocol, 
clinicians increased use of PHQ-9 to follow up positive screens on the PHQ-2.  The average 
post-intervention PHQ-9 score (17.75) was not significantly higher due to the small sample size, 
however; the pre-intervention average was substantially lower (7.5).  This suggests that the 
likelihood of clinicians using the PHQ-9 increased when included in a formalized protocol and 
reviewed in training sessions. Clinicians may have been more comfortable asking the screening 
questions and recording the answers post-intervention.  This may be because trained clinicians 
knew how to ask the questions and had programming available to help them decide how to make 
clinical decisions accordingly.   
 The idea that HH clinicians tend to be uncomfortable with depression screening, but that 
training can increase confidence, has been reported previously in the literature (Ell et al., 2005; 
Leibel & Powers, 2013; Brown et al., 2010).  Ell et al. (2005) reported in their study of 
depression screening in HH that nurses expressed feeling uncomfortable asking highly emotional 
questions and tended to avoid or put off discussions of difficult topics that would have come up 
during the screening process.  In a descriptive study of how HH nurses perceive depression 
management researchers found that some nurses believe they are unqualified to provide 
depression care alongside other chronic diseases (Leibel & Powers, 2013).  Generalist-nurses 
relayed feeling self-conscious (afraid of saying the wrong thing) when asking depression-
screening questions (Leibel & Powers, 2013).  The authors (Leibel & Powers, 2013) reinforce 
that training and formalized agency support for depression screening and care management leads 
to increased clinician comfort with depression screening and care (Brown et al., 2010). In a 
randomized study of the effects of the Training in the Assessment of Depression (TRIAD) 
	  37	  
program, researchers found that nurses who received training had significantly higher confidence 
in their ability to assess depressed mood (Brown et al., 2010). 
 An alternative interpretation of the PHQ-9 being administered more frequently post-
implementation points to the role of the MHN as an important factor. The protocol urged 
clinicians to refer patients with elevated PHQ-2 scores (three or greater) to the MHN who would 
then further evaluate using the PHQ-9 and follow up with depression care.  The specialized 
experience and training required of the MHNs may explain the increased rate of PHQ-9 
administration.  This factor was not controlled for and as a result complicates interpretation of 
this data point.  
 Clinicians referred patients with a PHQ-2 score of three or greater for a MHN evaluation 
at the same rate pre- and post-intervention.  This result may be interpreted several ways.  First, 
clinicians documented that a total of three patients refused the MHN evaluation when offered. 
Although, clinicians were trained to record a reason for not adhering to the protocol (to assist 
with program monitoring and modification) this was not routinely completed pre (13.3% 
completion) or post-training (8.3%).  Thus, rates of referring to a MHN per the protocol are 
probably not accurately described and may actually be higher than the data suggests.   
 The lack of change in rate of referral may also be explained by patient factors.  The 
stigma of mental illness continues to be a great barrier preventing many people from seeking 
care for treatable mental health conditions (Brown et al., 2007; Valente, 2005).  Even if the 
MHN referral was offered it is possible that some patients refused because of the negative 
associations that go along with admitting depression.  In other cases patients have established 
rapport and built trust with specific clinicians and so are reluctant to open up and tell their story 
again (Valente, 2005). 
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 Clinician and agency dynamics may also play a role in the low referral rate post program 
implementation. Throughout the duration of agency-wide training, currently employed MHNs 
resigned, and newly hired MHNs began orientation. The PI conducted training and gathered the 
data during a time of transition on the mental health team.  It takes time to train new nurses and 
prepare them for fieldwork; therefore staff coverage in some regions was light occasionally 
during the study. Anecdotally, some field clinicians indicated that it could take up to several 
weeks for a patient to be seen by a MHN. It is suspected that in a few cases the patients who 
scored greater than three on the PHQ-2 were not seen by a MHN because of staffing problems or 
because referring clinicians grew weary of the waiting and simply did not refer. However, the 
rationales for lack of referral were often not documented, and it is difficult to determine the 
impact of this factor on protocol adherence.  
 Among patients who scored three or greater on the PHQ-2 there were no significant 
differences in psychopharmacological treatment choices pre- versus post-implementation of the 
depressive disorder protocol.  This could partially be explained by the nature of the intervention. 
The depressive disorder protocol used at this agency urged clinicians to screen and then refer 
patients to a MHN for further evaluation and treatment. Patients who were receiving care from a 
MHN were not clearly identified and this factor was not controlled for in the data analysis; 
therefore this outcome is difficult to measure.   
 There was also no difference in the frequency of being diagnosed with a mood disorder 
pre- versus post-implementation.  It is probably true that this variable was measured too soon 
after implementation of the program and likely a better indicator of program impact on the 
agency coding and billing practices as well as Medicare reimbursement rules.  Medicare home 
health conditions of participation and payment structure tend to emphasize physical health and 
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create barriers for administrators and clinicians who strive to make providing quality mental 
health care a priority (Bao et al., 2014; Cabin, 2010).  Before design and implementation of the 
intervention agency leaders worked hard to justify the financial benefits of the mental health 
program and disprove fear that focusing clinician resources on depression and other mental 
illness would be financially untenable for the agency.  While this evaluation was not concerned 
with the cost-effectiveness of providing depression care, future research should focus on this area 
so that HH leaders are assured that depression care models can be comfortably implemented in 
the home care setting while improving the health of their patients.  
Limitations 
 Several limitations of the depressive disorder protocol process evaluation emerged and 
warrant mention. First, the descriptive design makes interpretation and generalization of the 
process evaluation results difficult.  Secondly, the sample size was quite small because of the 
limited time frames from which the data was reviewed and the infrequency of patients meeting 
inclusion criteria.  In charts of patients who did meet criteria for inclusion, the PI found data in 
various places within the EMR.  Clinicians did not use the same areas of the EMR to document 
information regarding the depressive disorder protocol or non-adherence to the guidelines.  In 
this case accuracy of data retrieval is challenged.  Both of these limitations call into question the 
ability of the data to explain current practices and, thus, make it difficult to make informed 
recommendations. 
 Before future program monitoring efforts begin it is recommended that clinicians be 
notified of exact locations in the EMR where they are to document specific pieces of information 
about the depressive disorder protocol.  Also, researchers are encouraged to utilize a time series 
approach over periods of months in lieu of a descriptive design so that threats to validity are 
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decreased and so that evaluation results are more clearly a reflection of the current state of 
practice (Linden, Adams, & Roberts, 2003).   
The Doctor of Nursing Practice to Promote Positive Change 
 As the terminal practice degree in the field, the Doctor of Nursing Practice (DNP) 
prepares clinical nurse scholars to lead the dissemination of safe, quality, and innovative 
healthcare around the globe (Chism, 2010).  With a firm understanding of how the evidence-base 
should inform and guide practice, the DNP is well positioned to improve how depression is 
addressed and treated in the elderly HH population. The DNP curricula cultivate competencies 
necessary for leadership and growth in all nursing specialties, including psychiatric/mental health 
care. Using the eight Essentials of Doctoral Education for Advanced Nursing Practice developed 
by the American Association of Colleges of Nursing, the DNP education prepares nurse leaders 
who understand the complexities of healthcare systems and who are also dedicated to continuous 
practice improvement at all stakeholder levels. These essentials help to explain how the DNP can 
be leveraged to promote positive practice change in this area (Chism, 2010). 
 DNP graduates are trained to use information technology to track program, financial, and 
clinical outcomes in order to evaluate and enhance practice (Essential IV; Chism, 2010).  Before 
administrators endeavor to conduct future evaluations of the mental health program, steps should 
be taken to improve the agency’s ability to use software and reports to monitor mental health 
program processes and clinical outcomes.  First it is critical that clinicians are documenting 
information in the same place within the EMR.  This agency uses a software package that 
encourages thoroughness of documentation, however; data collection can be time consuming and 
difficult if the data are not located in a predetermined location.  One solution is to direct 
clinicians to create a case communication note with a heading “Mental Health” to communicate 
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their impressions, assessments, interventions, and referral suggestions as they pertain to the 
patient’s mental health as well as the patient’s response.  This could involve a “cut and paste” of 
a clinical note or additional documentation of their concerns and recommendations.   
 Similarly, evaluations could be conducted more smoothly if quick reports could be 
generated. It is common within this agency to keep track of patient and clinician statistics with 
the simple click of a mouse and conjuring of a report.  Patients who receive services from a 
MHN should be assigned to a mental health team and important clinical and financial outcomes 
should be defined in the treatment plan.  This evaluation could have been more in depth if the PI 
had been able to generate a report of all the patients who scored three or greater on the PHQ-2.  
However, every patient admission (over 1,300) had to be opened and screened for the PHQ-2 
score first. As a marker for depression and depressive disorder protocol use, it is recommended 
that administrators request that reports of patients who screen positive on the PHQ-2 be available 
through their software vendor(s). 
 Understanding the importance of using data to inform practice, the DNP prepared nurse 
uses scientific findings from a variety of sources to evaluate and further develop care delivery 
(Essentials I, II, & III; Chism, 2010). It is recommended in this case that this descriptive 
evaluation be followed up by a qualitative design investigating clinician perceptions of the 
usefulness and function of the mental health program and depressive disorder protocol.  It is 
important to know from the people who see and care for these patients every day, “Is it 
working?”  The agency may find common themes emerge that would identify areas for process 
and quality improvement. 
 Even with a fairly large mental health team this process evaluation indicated that some 
patients who have clinically significant depression scores were not seen by a MHN. It is not 
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reasonable for ten nurses to serve the depression care needs of 310 patients (13% of average 
monthly census–estimated population of HH patients who will meet criteria for clinically 
significant depression).  One solution to problems with coverage and long wait times is to train 
all nurses to manage depression. Embracing more of a collaborative care model, the agency 
might choose to train all 150 nurses to manage depression like other chronic diseases. Doctoral-
level prepared psychiatric/mental health nurses are trained to emphasize the importance of 
collaborative care among interdisciplinary teams and can provide specialized education on 
depression screening and care to skilled nurses and other HH personnel (Essential VI; Chism, 
2010). 
  DNP clinicians examine healthcare policy at all stakeholder levels and create feasible 
solutions to increase access to quality healthcare (Essential V; Chism, 2010). As described, some 
existing HH policies do not support the provision of depression care in this population.  The 
following manuscript considers this and offers suggestions for sensible policy changes at both 
federal and local levels.    
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Table 1. Coding of Process Indicators/Outcomes 
 
 
 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
Process Indicator/Outcome Chart Item Reviewed Coding–
Present/Not 
Present 
Was PHQ-9 administered according 
to protocol?  
PHQ-9 completed 1/0 
Was a MHN referral made according 
to protocol? 
MHN referred and completed evaluation. 
Reviewed orders, case communication 
notes, and visit tree. 
1/0 
Did patient have primary or 
secondary mood disorder diagnosis? 
Home health diagnoses found on patient 
profile 
1/0 
Was patient prescribed an 
antidepressant during home health 
episode(s) of care? 
Medication list  1/0 
Was patient prescribed a 
benzodiazepine during home health 
episode(s) of care? 
Medication list 1/0 
	   	   	  
	  48	  
Table 2. Differences in sociodemographic characteristics pre- and post-intervention  
 
  
Overall sample  
(N =58) 
  
Pre  
(n =30) 
 
  
Post   
(n =28) 
 
p-value* 
  
 
 
 
 
 
 
Age, mean                                                          
 
71.5 	   72.2  70.7 .78 
Female, n (%) 
 
41 (70.6)  20 (66.6)  21 (75)  .48 
Race/ethnicity, n (%) 
   White, non-Hispanic 
48 (82.7)   24 (80)  24 (85.7) .76 τ 
___________________________________________________________________________________________________________	  *p-­‐values	  based	  on	  t-­‐test	  or	  chi-­‐square	  analysis	  	  
τ	  White,	  non-­‐Hispanic	  vs.	  others	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Table 3. Process Indicators  
 
  
Overall sample  
(N =58) 
  
Pre  
(n =30) 
 
  
Post   
(n =28) 
 
p-value* 
  
 
 
 
 
 
 
PHQ-2 score, mean 
 
4.44  4.67  4.21 .095 
PHQ-9, n (%) 
 
10 (17.2)  2 (6.6)  8 (28.6)  .038 τ 
PHQ-9 score, mean 14.1  7.5  17.75 .06  
       
MHN referral, n (%) 31 (53.4)  15 (50)  16 (57.1) .61 
___________________________________________________________________________________________________________	  
*p-values based on t-test or chi-square analysis  
τ	  fisher’s exact test	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Table 4. Process Outcomes  
 
  
Overall sample  
(N =58) 
  
Pre  
(n =30) 
 
  
Post   
(n =28) 
 
p-value* 
  
 
 
 
 
 
 
1 or 2 Mood D/O dx, n (%) 
 
10 (17.2)  5 (16.6)  5 (17.9) .905 
Antidepressant, n (%) 
 
30 (51.7)  16 (53.3)  14 (50)  .80 
Benzodiazepine, n (%) 20 (34.5)  11 (36.6)  9 (32.1) .72  
________________________________________________________________________________________________________	  
*p-values based on t-test or chi-square analysis  	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Table 5. Protocol Non-Adherence 
Documentation of protocol 
non-adherence 
Pre Post  
Use of PHQ-9 GAD completed instead. Anxiety 
primary MH problem. 
Not appropriate for 
patient presentation. 
 Geriatric depression scale used.   
MHN referral  Pt. refused MHN service (n = 2) Patient refused MHN 
service (n =1) 
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Figure 1. Percentage of Times Clinicians Properly Documented Non-adherence 	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Improving Depression Care for Elderly Home Health Patients:  
Suggestions for Policy Change 
Depression is a widespread mental health issue in the home healthcare (HH) population 
(Bruce et al., 2015).  Depressive symptoms exhibited by homebound and chronically ill older 
adults often go under reported and undertreated (Sheeran et al., 2010) and are associated with 
increased rates of re-hospitalization (Sheeran, Byers, & Bruce, 2010), falls (Byers et al., 2008), 
and suicides (Raue et al., 2006). Additionally, healthcare costs are two times higher for patients 
diagnosed with diabetes or heart disease with a co-morbid diagnosis of depression (INFOMC, 
2013). In 2011 the Centers for Medicare and Medicaid (CMS) recommended the use of a quick, 
two-item depression-screening tool, the Patient Health Questionnaire (PHQ) 2, on the Outcome 
and Assessment Information Set (OASIS) C to promote recognition of depression in the HH 
population.  “How often the HH agency checked patients for depression” is now a quality 
measure tracked by CMS. This CMS policy change has prompted HH agencies to recommend 
that clinicians screen for depressive symptoms and screening is facilitated by inclusion of the 
PHQ-2 in the OASIS-C assessment. However, CMS and the HH model offer little else to 
encourage and support depression care.  Therefore, additional polices at both the national and 
local levels are needed to improve the provision of depression care in this population. This 
manuscript will describe depression in the HH population and explore current evidence-based 
programming options for HH agencies. Finally, recommended national and local level policy 
changes will be identified.  
The Problem of Depression 
Older adults in need of HH services are typically homebound and require care and 
monitoring of chronic health conditions such as cardiovascular diseases, diabetes, and chronic 
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pulmonary disorders (Qui et al., 2010).  Beck et al. (2009) reported that over 40% of homebound 
elders in their program were diagnosed with at least two comorbid medical and mental illnesses.  
Twelve to 25% of elders receiving HH meet the criteria for clinical depression, and these 
estimates are considered conservative because mental illness is frequently not recognized (Bruce 
et al., 2002; Bruce et al., 2015).  In one study only 22% of elders who met criteria for depression 
were being treated with antidepressants, and none were involved with psychotherapy (Bruce et 
al., 2002).  Raue et al. (2011) found that 32% of patients who met criteria for major or minor 
depression were being treated with an antidepressant; however, none were receiving 
psychotherapy, despite the finding that 18% reported wanting to be involved with this type of 
treatment. These data highlight significant gaps in mental health care treatment for elderly HH 
patients, particularly regarding depression, even though the consequences of untreated 
depression have been well described.   
Depression complicates the treatment of chronic illness from multiple angles (Katon, 
2011).  The mood disorder can impede chronic care management and worsen the symptom 
burden of illnesses common in older age (Katon, 2011).  Negative thinking and feelings of 
apathy and hopelessness characteristic of depressive illnesses can lead to poor adherence to strict 
medical regimens needed to keep chronic illnesses like diabetes (Acee, 2014) and heart failure 
(Thomas et al., 2008) under control. Even the practitioner-patient relationship can be negatively 
impacted due to the practitioner perceiving the treatment course as more complicated and 
involved when a patient is depressed (Katon, 2011). Also, hormonal and immune responses 
typical of depressive states can exacerbate chronic illness and limit treatment efficacy (Katon, 
2011; Thomas et al., 2008). 
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This may partly explain why depression increases elderly HH patients’ risk for short-term 
re-hospitalization (Sheeran, Byers, & Bruce, 2010).  CMS is focusing on reducing rates of 
hospitalization as part of ongoing efforts to reduce costs in an out-of-control healthcare spending 
climate; therefore, it is worthwhile to better understand complex factors that contribute to these 
rates. In one study, depressed patients were hospitalized sooner after admission to HH than non-
depressed patients (Sheeran, Byers, & Bruce, 2010).  Also, the depressed patients had a 
significantly higher risk of re-hospitalization within the first 2-3 weeks of receiving HH 
(Sheeran, Byers, & Bruce, 2010).  In another study of a sample population with a mean age of 
61, depressive symptoms were associated with increased rates of re-hospitalization following an 
acute myocardial infarction (MI; Reese et al., 2011).  Of additional importance, 33% of elderly 
adults fall each year and are hospitalized for fall-related injuries five times more often than for 
any other adverse event (Centers for Disease Control [CDC], 2014].  In a 2008 (Byers et al.) 
study it was found that HH patients who fell were twice as likely to be depressed.  Clearly, 
screening and interventions for depression should be a priority in HH efforts to prevent adverse 
events and treat chronic illnesses.  
Depression Care in Home Health Policy 
Since July of 1999 Medicare has required clinicians who admit Medicare recipients to 
HH to complete the OASIS–a lengthy and comprehensive assessment that calculates each 
patient’s Home Health Resource Group (HHRG) score and case-mix adjustment index.  Home 
healthcare agencies are paid for each 60-day episode of care using a prospective payment system 
(PPS) that adjusts payment to reflect each patient’s HHRG and case-mix.  
Until January 2010, OASIS item M0590, which consisted of a checklist of some of the 
symptoms of major depression, was used to screen for depression. While this item required the 
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HH clinician to address depression in some form, it lacked standardization, assessment of 
anhedonia, and symptom degree as well as persistence, failing to capture the full patient 
presentation.  Perhaps most importantly, the item was placed on the OASIS without direction 
about how to ask the questions or what to do with the answers (Sheeran, Reilly, Weinberger, 
Bruce, & Pomerantz, 2010).  
In 2010 the OASIS-C was introduced and item M0590 was replaced by M1730, which 
addressed some of these deficits.  Item M1730 asks whether a standardized tool was used to 
screen the patient for depression, allowing each agency to choose which tool they use.  This item 
outlines instruction for administration of the PHQ-2 if no other instruments are used, providing 
access to a quick, standardized depression-screening tool.  The PHQ-2 measures both key 
symptoms of depression (depressed mood and anhedonia) as well as symptom pervasiveness and 
persistence (Sheeran, Reilly, Weinberger, Bruce, & Pomerantz, 2010).  This tool even gives the 
clinician some guidance on how to ask the questions and score the answers, and it encourages the 
clinician to consider whether additional evaluation is necessary.  Noticeably, improvements have 
been made to the way in which the OASIS prompts clinicians to screen for depression. However, 
individual HH agencies vary widely in their use of this tool in the home setting.  
Ongoing Effort to Integrate Depression Care in Home Health 
 According to The United States Preventative Services Task Force it is recommended that 
clinicians conduct “screening for depression in adults aged 18 and older when staff-assisted 
depression care supports are in place to assure accurate diagnosis, effective treatment, and 
follow-up” (2002).   In other words, unless an agency has a clear action plan for treatment in the 
event of a position depression screen, the USPSTF recommends against screening.  CMS does 
not mandate that HH agencies screen for depression; however, the rate at which the HH agency 
	  58	  
checked for depression is a quality measure CMS monitors and publicizes.  Also, the OASIS-C 
asks that clinicians consider if depression intervention(s) such as medication, referral for other 
treatment, or a monitoring plan for current treatment will be used.  Again, however, care 
management of depression is not required. These prompts and reportable quality measures 
appear to be the extent of the oversight CMS provides to HH agencies for depression care. 
Unfortunately, several broad-based Medicare policies do not make provision of 
depression care appealing to HH agencies and, as a result, depression care is rarely integrated 
into HH. Cabin (2010) addressed this issue writing,  “To date, the OASIS has not placed any 
burden on Medicare HH agencies to assess, screen, or intervene for depression, nor is there any 
reward in the per-episode payment or quality measurement system” (Cabin, 2010, p. 172). 
The presence (or absence) of a diagnosis of depression in a HH patient has no effect on 
the HHRG score and, therein, has no impact on the amount of money paid to the HH agency to 
care for the patient. In other words, there are no explicit financial incentives for providing quality 
depression care. In fact, some HH agencies consider the provision of depression care a financial 
nightmare.  The PPS system financially incentivizes seeing as many patients as possible in as 
little time as possible. This reward system is heavily misaligned with provided quality and 
thorough chronic care management, especially potentially time-intensive depression care (Bao, 
Eggman, Richardson, & Bruce, 2014).  As a result, most HH agencies do not see the value in or 
financial feasibility of integrating depression care programming in operations.  Even though 
leaders may understand the importance of identifying and addressing depression, some say it is 
difficult to see financial benefit. (Bao et al., 2014).  
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Evidence-Based Depression Care for Home Health 
The U.S. Department of Health and Human Service Substance Abuse and Mental Health 
Services Administration (SAMHSA, 2011) recognizes that many older adults do not have access 
to evidence-based depression support when needed.  To address this need the agency stated, 
“EBPs must be available in the settings where older adults receive their care” (SAMHSA, 2011, 
p. 10). What better place to intervene than in the homes of older homebound adults? 
Researchers have recognized the need for HH-friendly, evidence-based depression care 
management programs and a few have been developed (Bruce et al., 2015; Ell et al., 2007; 
Madden-Baer, McConnell, Rosati, Rosenfeld, & Edison, 2013). For example, the Psychogeriatric 
Assessment and Treatment in City Housing (PATCH) is an in-home program that stresses 
depression education for important people in seniors’ lives as well as care coordination (Robbins, 
Rye, German, Tlasek-Wolfson, Penrod, Rabins, & Black, 2000).  The Program to Encourage 
Active Rewarding Lives for Seniors (PEARLS) uses goal setting and problem solving in the 
home to reduce depressive symptoms and improve patients’ quality of life (SAMSHA, 2011).  
Other in-home depression care programs for seniors emphasize staff education and encourage 
case communication among providers to report depressive symptoms and response to treatment, 
monitoring of medications, goal setting, and connection to community-based services (Pickett, 
Raue, & Bruce, 2012).  A few have been developed with stakeholder interests and HH agency 
realities in mind (Bruce et al., 2015; Gellis, Kenaley, & Have, 2014).  
Depression care can be successfully adopted and integrated into routine HH agency 
operations and can result in clinically significant outcomes in moderately to severely depressed 
patients (Bruce et al., 2015).  Six HH agencies from across the nation participated in a 
randomized trial to test the clinical effectiveness of Depression CAREPATH, a program for 
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integrating depression care into routine nursing practice.  Depression CAREPATH is unique in 
that agencies are encouraged to train all nurses to assess for depression and provide a variety of 
interventions as appropriate or as time allows. In this way depression is viewed as a chronic 
illness that the nurse would address alongside other diseases (Bruce et al., 2015).  
This method of depression care is based on the Collaborative Care Model [CCM], which 
is recognized globally as an effective and necessary method of integrating mental and physical 
health care (Ngo et al., 2013). The CCM encourages a team-based approach to the identification 
and treatment of mental illness so that roles are adapted to: 
 Routinely identify patients who need care; assess risk factors; educate patients about 
 their illness, risk factors and treatment; intervene with a combination of brief 
 evidence-based pharmacological and psychosocial treatments; teach self-management 
 skills; monitor patients’ progress and adherence to treatment; and follow-up over the long 
 term (Ngo et al., 2013, p. 1).   
Multiple randomized-controlled trials have reported that collaborative outpatient care for 
common mental health conditions, such as depression, is more clinically- and cost-effective 
compared to standard treatment options (Unutzer, Harbin, & Schoenbaum, 2013). Improving 
Mood, Promoting Access to Collaborative Care (IMPACT, 2012) is a well-described and 
thoroughly researched collaborative care model implemented in primary care clinics where older 
adults receive care.  This model uses collaboration, depression care managers, psychiatrists, 
outcome measurement, and an evidence-based treatment algorithm to treat depression in older 
adults (IMPACT, 2012). In 2012, IMPACT had twice the effectiveness of treating depression 
than treatment as usual. These positive effects lasted for at least one year after treatment ceased. 
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For this reason, researchers are recommending that this model be implemented in the newly 
developed Medicaid Health Homes (Unutzer, Harbin, & Schoenbaum, 2013).  
Clearly, researchers have created, tested, and made solutions available.  The next steps 
are engaging stakeholders and implementing these programs for the benefit of our older 
American citizens. 
Stakeholder Interests  
When a need for integrated depression care for older adults has been identified, large-
scale government agencies have called for solutions (SAMHSA, 2011).  Delegates from the 2005 
White House Conference on Aging reported the need to “improve recognition, assessment, and 
treatment of mental illness and depression among older adults” as one of the top 10 resolutions.  
The 2015 Conference will continue to explore healthy aging.  In addition, CMS has expressed a 
commitment to address the issue, although on a broader scale. The center has recently submitted 
a proposed rule that would change the HH agency conditions of participation to encourage a 
“more continuous integrated care process across all aspects of home health services, based on a 
patient-centered assessment, care planning, service delivery, and quality assessment and 
performance improvement” (Medicare and Medicaid Program: Conditions of Participation for 
Home Health Agencies, 2014, p. 61166). The proposed changes emphasize the importance of 
assessing patients’ psychosocial status and improving clinicians’ ability to understand how social 
and emotional factors contribute to health outcomes (Medicare and Medicaid Program: 
Conditions of Participation for Home Health, 2014).  
The successful passage of these resolutions by congressional committees depends on the 
ability of CMS and HH agencies to identify and implement cost-effective and clinically 
efficacious ways to integrate care of common physical and mental health problems.  CMS needs 
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to encourage this practice without creating exorbitant costs to the already financially strapped 
Medicare fund. In addition, HH agencies should implement these changes without breaking the 
budgets of HH agencies or expanding the workloads of already-overwhelmed HH clinicians.  
Both groups should ideally identify and implement solutions that have been shown to effectively 
adapt to HH operations and be useful rather than burdensome for HH clinicians.   
Generalist nurses have asked for training that enhances their ability to accurately assess 
depression and provide effective management of this mental health problem (Liebel & Powers, 
2013).  HH nurses, due to their holistic training and approach to care, would like to be able to 
intervene when their patients are depressed (Bao, Eggman, Richardson, & Bruce, 2014).   
Depression is not a normal part of aging. Older adults deserve to have the option for care 
and treatment of this disabling mental condition. In one study only 10% of patients who met 
criteria for depression preferred to do nothing about their mental distress–the majority reported 
wanting to feel better (Raue, Weinberger, Sirey, Meyers, & Bruce, 2011).  While stigma and 
negative attitudes toward mental health treatment persist among older adults, HH clinicians 
should be prepared to identify and discuss depressive symptoms with their patients. 
Policy Changes 
Given the breadth of the problem of depression in the HH population and the 
consequences of leaving it unaddressed, CMS and HH agency policy changes are needed.  Policy 
options range from doing nothing to fully restructuring the reimbursement policies for HH 
agencies provision of care to depressed patients. However, it is crucial to identify and implement 
policies that optimize integration of physical and mental health care, yet simultaneously maintain 
reasonable clinician workloads. Common sense, low-risk actions can be taken at both a federal 
and local level. 
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Policy Recommendations 
 Recommendation 1: Provide additional access to evidence-based depression care 
programming through the CMS website. Currently CMS provides an OASIS-C1/ICD-9 
Guidance Manual available for download on their website.  This manual was recently posted to 
the CMS website (2014) and includes resources for various aspects of HH agency operations, 
including depression care and administration of the PHQ-2; however, the information pertaining 
to depression care is limited and out of date.  The last update to the information was made in 
2012 using research and resources that were developed before 2011, before significant changes 
were made to the OASIS that impacted how HH clinicians screen for and are prompted to care 
for depressed patients. HH agencies might consider implementing depression care programming 
if they were more aware of various options for depression care programming that could be 
adapted to their unique set of resources and operations. This resource list should be expanded to 
include various options for home-based depression care that can be found in the literature and 
through the Agency for Healthcare Research and Quality (AHRQ).    
 In addition it would be helpful for CMS to create a web-based open forum for HH 
agencies to discuss barriers as well as successful implementation of evidence-based depression 
care programming.  Encouraging leaders to discuss goals, failed attempts, as well as successes 
could promote realistic implementation of depression care.  
 Recommendation 2: CMS can link implementation of evidence-based depression 
care to conditions of participation.  As previously discussed, CMS is proposing significant 
changes to HH agencies’ conditions of participation. It is recommended that HH agencies 
improve the way they assess and address patients’ psychosocial status, which could increase the 
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likelihood that HH agencies will make important changes to regulations and policies.  Moreover, 
an evidence-based approach to implementation could improve these odds.  
 Recommendation 3:  Local HH agency policies should reflect the importance of 
depression care as part of chronic illness management. On a local level, HH agencies can 
acknowledge the importance of identifying and addressing depressive symptoms by making 
depression care management a priority.  HH leaders should be seeking out innovative ways to 
adapt and implement depression care in their own agencies. Although not every program is well 
suited for every HH agency, clinicians can be trained and protocols adapted to improve agencies’ 
ability to intervene. At the very least agencies need to have a suicide assessment and intervention 
protocol for their clinicians’ awareness and their patients’ protection. 
 Home healthcare agencies have successfully designed and implemented chronic care 
management programs for diabetes, CHF, and COPD, and similar programs can be developed for 
depression. Organizations can train nurses to effectively screen for depression, monitor 
antidepressant medications, and collaborate with prescribers (Bruce et al., 2015).  Goal setting 
and problem solving are useful skills for nurses to use with all patients, regardless of a diagnosis 
of depression. While the OASIS only prompts for depression screening at admission, HH 
agencies can choose to reassess symptoms of depression to measure patient progress and 
intervention effectiveness. Guidelines are available for assessment and reassessment using the 
PHQ-2 and PHQ-9 (Bruce et al., 2011a; Bruce et al., 2011b).  
Impact 
 Untreated and undertreated depression in the HH population contributes to numerous 
poor health outcomes (Sheeran, et al., 2010, Byers et al., 2008, Raue et al., 2006).  Traditionally, 
CMS and HH agency policies have not been adequately aligned with the provision of evidence-
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based depression care.  Depression care in home health will not improve without making 
important policy changes.  
 On the other hand, implementing policies that encourage HH agencies to make 
depression care a priority can alleviate patients’ symptoms, especially patients with more 
moderate to severe, debilitating depression (Bruce et al., 2015). Adapting the collaborative care 
model for depression and chronic illness has improved patients’ engagement in treatment, their 
overall physical functioning, and their quality of life (Hunkeler et al., 2006).  These 
improvements are key in assisting chronically ill older adults to better manage their illnesses to 
prevent costly re-hospitalizations and lethal exacerbations.   
 The National Council on Aging (2014) reports that our current method of providing care 
for chronically ill people accounts for approximately 75% of our nation’s spending on health 
care, while only one percent of funds are budgeted to improve patients’ ability to manage their 
illnesses. Depressed patients are 1.75 times more likely to be non-adherent to prescribed 
treatment regimens compared to their non-depressed peers (Grenard et al., 2011), and can care 
can cost twice that of non-depressed patients (INFOMC, 2013). Chronic illnesses are expensive, 
especially if we do not support efforts to tackle key problems, such as depression.  
 As the US healthcare system undergoes significant transformations, the importance of 
addressing mental illness will garner significant attention. HH agencies that have considered 
options for incorporating depression care and have started to do so will be at a significant 
advantage.  Hospital systems and outpatient care providers are beginning to see the importance 
of targeting mental health efforts to improve chronic illness management.  Agencies that adopt 
smart, innovative options for doing so will remain competitive and be able to provide true 
holistic care to chronically ill older adults. 
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Conclusion 
 As described in the first manuscript depression is associated with multiple negative health 
outcomes and should be a part of chronic disease management programs implemented in home 
healthcare (HH).  Unfortunately, patient, clinician, agency, and policy barriers impede effective 
depression care delivery in the HH population.  Even so, research has shown that depression care 
programming can improve nurses’ ability to effectively screen for depressed patients (Brown et 
al., 2010; Bruce et al., 2007) and reduce depression scores, especially in patients with moderate 
to severe levels of depression (Bruce et al., 2015).  
 While HH clinicians in this report were trained to screen patients for depression and refer 
patients who scored high during admission, results of the process evaluation indicated that 
additional steps must be taken by the HH agency so that future evaluation efforts more 
accurately reflect clinician practice.  Interpreted cautiously, the process evaluation indicated that 
while training did improve clinician use of the PHQ-9, practice did not drastically change after 
protocol implementation. Not all patients who met criteria for further evaluation and treatment 
based on initial screening using the PHQ-2 received depression care. The researcher suggested 
this could be due to protocol reliance on inadequate numbers of specialized mental health 
clinicians.  Additionally, it is suspected that Medicare policies that are not clearly supportive of 
depression care contribute to this finding. However, there are several ways in which the DNP can 
initiate practice change to increase access to depression care and improve depression outcomes 
for elderly HH patients.  
 The final manuscript investigated ways in which local and national level policies can be 
changed to encourage the use of evidence-based, in-home depression care programming. Like all 
areas of healthcare, home health resources are limited and budgets must be carefully considered.  
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Depression care models that understand the realities of HH have been developed and suggest that 
all nurses should be trained to screen and provide interventions within their scope of practice 
(Bruce et al., 2015).  This increases the number of adequately trained professionals available to 
manage the mental health condition and improves the likelihood that all depressed patients will 
have access to depression care. Medicare policies should reward agencies and clinicians who 
chose to improve chronic care management by using evidence-based depression care. 
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Appendix A 
The Patient Health Questionnaire-2 (PHQ-2)     
Over the past 2 weeks, how often have you been 
bothered by any of the following problems? Not At All 
Several 
Days 
More 
Than Half 
the Days 
Nearly 
Every 
Day 
1. Little interest or pleasure in doing things 0 1 2 3 
2. Feeling down, depressed or hopeless 0 1 2 3 
(Kroenke, Spitzer, & Williams, 2003) 
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Appendix B 
 
Appendix B 
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Appendix C 
Tips for Administering the PHQ-2 
 
1. Aim to ask the questions in a straightforward and empathetic manner. For example you may 
want to say, “Now I’m going to ask you some questions about how you’ve been feeling.” 
The more comfortable you are asking the questions, the more comfortable your patient will 
be answering these questions honestly and thoroughly. 
2. It is important to screen for depression even if the patient is already taking an antidepressant 
medication at admission. There are several reasons why a patient who is taking an 
antidepressant may still be depressed and need additional intervention. 
3. Consider the following suggestions for asking the PHQ-2 questions: 
a. Split the question into “bite sized” pieces. For example, “Have you had little interest or 
pleasure in doing things?” If yes...”How long have you been feeling this way?” or 
“Have you been feeling this way for at least two weeks?” How often have you been 
feeling this way? Several days, more than half the days, or nearly every day?” 
b. You may want to use the large print response card so that your patients can read the 
options and chose what best fits their experience. This can reduce confusion and 
work better for visually and hearing impaired patients. 
4. If a patient has severe cognitive impairment, the PHQ-2 may not be a reliable screening 
tool. You can try to answer the questions using caregiver response; however, this is also 
not the most reliable way to use this screening instrument. If you think that the PHQ-2 is 
not a reliable screener for your patient and you suspect your patient may have depressive 
symptoms consider a MHN evaluation to further screen for depression. 
5. Cutoff scores for the PHQ-2 are as follows: 
a. < 3: correctly identifies 78% of patients who are not 
depressed b. > 3: correctly identifies 87% of patients who are 
depressed 
7. If your patient scores > 3 on the PHQ2, talk to them and/or the caregiver about the MHN 
service. Here are some ways you might initiate that conversation with your patient 
and/or their caregiver: 
a. “Based on your responses to this screening tool, it seems like you may be struggling with 
some feelings of depression. Would you agree to talk to one of our nurses who 
specializes in helping people cope with those feelings?” 
b. “I’m concerned that you may need more intensive help with your feelings of depression. 
I’d like to ask for one of our mental health nurses to see you. Would that be ok with you?” 
c. If there is already a prescription, “Your MD/NP would like for one of our MHNs to see you 
about your feelings of depression. They will be by within the week to visit with you and  
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